Vigabatrin and complex partial status.
Arzimanoglou
A
A
D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004569:Electroencephalography / Q000187:drug effects; D017029:Epilepsy, Complex Partial / Q000139:chemically induced*; D005071:Evoked Potentials / Q000187:drug effects; D006801:Humans; D013226:Status Epilepticus / Q000139:chemically induced*; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; D020888:Vigabatrin